“Under consideration, ok only after Aifa”

The “fourth dose” of the anti-Covid vaccine, “exclusively for the immunocompromised, is subject to evaluation by our scientific community. Only after the pronouncement of Aifa”, the Italian drug agency, “will eventually be authorized”. This was specified by the Ministry of Health, after the Piedmont Region announced the start of the fourth administration for immunosuppressed subjects.

Read also